Wells Fargo’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.71K Sell
5,508
-14,818
-73% -$20.7K ﹤0.01% 5554
2025
Q1
$32.7K Buy
20,326
+332
+2% +$535 ﹤0.01% 5078
2024
Q4
$25.2K Buy
19,994
+5,435
+37% +$6.85K ﹤0.01% 5204
2024
Q3
$27.4K Sell
14,559
-365
-2% -$686 ﹤0.01% 5144
2024
Q2
$110K Buy
14,924
+1,257
+9% +$9.3K ﹤0.01% 4518
2024
Q1
$107K Buy
13,667
+1,224
+10% +$9.58K ﹤0.01% 4481
2023
Q4
$63.2K Buy
12,443
+1,736
+16% +$8.82K ﹤0.01% 4763
2023
Q3
$63.4K Sell
10,707
-5,394
-34% -$31.9K ﹤0.01% 4712
2023
Q2
$119K Buy
16,101
+10,625
+194% +$78.8K ﹤0.01% 4663
2023
Q1
$51.7K Buy
5,476
+4
+0.1% +$38 ﹤0.01% 4855
2022
Q4
$58.3K Buy
5,472
+405
+8% +$4.31K ﹤0.01% 4492
2022
Q3
$37K Buy
5,067
+8
+0.2% +$58 ﹤0.01% 4778
2022
Q2
$25K Buy
5,059
+23
+0.5% +$114 ﹤0.01% 5053
2022
Q1
$26K Buy
5,036
+1
+0% +$5 ﹤0.01% 5581
2021
Q4
$30K Sell
5,035
-475
-9% -$2.83K ﹤0.01% 5699
2021
Q3
$49K Buy
5,510
+3,961
+256% +$35.2K ﹤0.01% 5328
2021
Q2
$12K Buy
1,549
+175
+13% +$1.36K ﹤0.01% 5741
2021
Q1
$11K Sell
1,374
-16,006
-92% -$128K ﹤0.01% 5939
2020
Q4
$136K Buy
17,380
+16,811
+2,954% +$132K ﹤0.01% 5090
2020
Q3
$6K Buy
569
+48
+9% +$506 ﹤0.01% 5653
2020
Q2
$5K Hold
521
﹤0.01% 5605
2020
Q1
$3K Buy
521
+34
+7% +$196 ﹤0.01% 5605
2019
Q4
$3K Buy
+487
New +$3K ﹤0.01% 5713
2015
Q3
Sell
-122
Closed -$10K 5870
2015
Q2
$10K Buy
122
+63
+107% +$5.16K ﹤0.01% 5559
2015
Q1
$4K Buy
59
+26
+79% +$1.76K ﹤0.01% 5622
2014
Q4
$6K Hold
33
﹤0.01% 5556
2014
Q3
$7K Sell
33
-14
-30% -$2.97K ﹤0.01% 5526
2014
Q2
$10K Buy
+47
New +$10K ﹤0.01% 5462